ERIN JAKOVAC: Open Payments
NPI 1003574914 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 38 payments from 15 companies in 2025. Trend: 2023 $1,744 · 2024 $1,354 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $142 |
| Xeris Pharmaceuticals, Inc. | 6 | $107 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $84 |
| Corcept Therapeutics | 3 | $75 |
| Amneal Pharmaceuticals LLC | 3 | $69 |
| Medtronic, Inc. | 1 | $66 |
| Amgen Inc. | 3 | $52 |
| Mannkind Corporation | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Ascendis Pharma Endocrinology Inc | 2 | $41 |
Products named: RECORLEV, ISTURISA, Korlym, Ozempic, Wegovy, UNITHROID, MINIMED 780G, TEPEZZA.
Industry payments across MI — which companies pay providers there.
